Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.37 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.37 |
| ▸ | NAMPT | P43490 | 2/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | AKT1 | P31749 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14354273 | 1.00 | AGTR1 (0.40) | AGTR1CYP11B1CYP11B2PIK3CAPIK3C3 | |
| SCHEMBL14467201 | 0.92 | PIK3CA (0.37) | AGTR1CYP11B1CYP11B2PIK3CAPIK3C3 | |
| SCHEMBL14467197 | 0.92 | PIK3CA (0.37) | AGTR1CYP11B1CYP11B2PIK3CAPIK3C3 | |
| SCHEMBL12333391 | 0.82 | CYP11B1 (0.33) | AGTR1CYP11B1CYP11B2PIK3CAPIK3C3 | |
| SCHEMBL12333120 | 0.82 | HTT (0.40) | AGTR1CYP11B1CYP11B2PIK3CAPIK3C3 | |
| SCHEMBL29277557 | 0.77 | AGTR1 (0.49) | AGTR1CYP11B1CYP11B2PIK3CALOXL2 | |
| SCHEMBL12333390 | 0.75 | PIK3CD (0.44) | AGTR1CYP11B1CYP11B2PIK3CALOXL2 | |
| SCHEMBL29277555 | 0.70 | HTT (0.49) | AGTR1CYP11B1CYP11B2HTR6HTT | |
| SCHEMBL29277552 | 0.70 | CYP11B1 (0.47) | AGTR1CYP11B1CYP11B2HTR6HTT | |
| SCHEMBL7500750 | 0.67 | AGTR1 (0.46) | AGTR1CYP11B1CYP11B2PIK3CAHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2557081-A1 | THIENOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME AND ORGANIC SEMICONDUCTOR DEVICE USING SAME | Hiroshima University (JP) | 2013-02-13 | — | — | EP | disclosed |
| EP-2557081-A1 | THIENOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME AND ORGANIC SEMICONDUCTOR DEVICE USING SAME | Hiroshima University (JP) | 2013-02-13 | — | — | EP | disclosed |
| US-20130005979-A1 | THIENOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME AND ORGANIC SEMICONDUCTOR DEVICE USING SAME | KURARAY CO. LTD. (JP) | 2013-01-03 | — | — | US | disclosed |
| US-20130005979-A1 | THIENOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME AND ORGANIC SEMICONDUCTOR DEVICE USING SAME | KURARAY CO. LTD. (JP) | 2013-01-03 | — | — | US | disclosed |
| WO-2011115071-A1 | THIENOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME AND ORGANIC SEMICONDUCTOR DEVICE USING SAME | 国立大学法人広島大学 (JP) | 2011-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005979-A1 | THIENOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME AND ORGANIC SEMICONDUCTOR DEVICE USING SAME | TPMT, TET1, TYMS | AGTR1 3449/4885CYP11B1 2118/4885CYP11B2 2264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.